Leveraging the Power of NKT Cell Targeting for Therapeutic Efficacy in Fibrotic Conditions
Time: 11:30 am
day: Day Two
Details:
- Innate-like adaptive Natural Killer T-cells that drive chronic inflammatory and fibrotic conditions
- NKT cells are elevated in patients with fibrosis, regulate the activity of both adaptive and innate immune responses, and are associated with progressive disease
- NKT cells are upstream of many of many of the key targets in fibrotic disease
